Read the details on Marketplace Wisconsin: The Governor’s Conference on Diverse Business Development

Hepalink

July 1, 2024
Share This Story:
Ariel photo of Hepalink plant in Waunakee

Hepalink finds path to prosperity in Waunakee

Wisconsin’s attributes, business climate help drive growth

Scientific Protein Laboratories, an Oscar Mayer spinoff begun in 1976, used Waunakee as a launch pad for growth. There, the company built the momentum to become a world leader in high-quality heparin and pancreatic enzymes—known as active pharmaceutical ingredients (APIs)— for the drug, veterinary, and food industries worldwide.

Specializing in biopharmaceutical manufacturing, the company was acquired for $337.5 million by Shenzen, China-based Hepalink in 2014. Founded in 1998, Hepalink produces, distributes, and sells heparin sodium to pharmaceutical companies globally. The acquisition gave the Scientific Protein Laboratories a more global reach and deeper access to research and development assets.

Growth keeps company on the cutting edge

At the time of the purchase, Hepalink CEO Li Li said Scientific Protein Laboratories would “strengthen Hepalink’s globally leading advantages in technology, processing techniques, quality, and safety standards, and form a global heparin API manufacturing, R&D, and distribution network for Hepalink.”

Scientific Protein Laboratories’ plant, expanded several times since 1976, also provides contract process development and cGMP manufacturing services, including heparin derivatives, natural products extraction, fermentation, and purification.

After its acquisition, Hepalink invested an additional $80 million in capital investments in the Waunakee facility. With about 270 employees, Scientific Protein Laboratories has established a proven track record in efficient process development, analytical testing, quality assurance, and regulatory support.

“Wisconsin has a stable workforce, well-trained technicians, skilled workers, a highly developed and respected education system, reasonable labor costs, and low land and utility costs.”

Shawn Lu

Chief Financial Officer, Hepalink USA

Wisconsin provides a strong business climate

Shawn Lu

Shawn Lu, Chief Financial Officer, Hepalink USA

Acquiring Scientific Protein Laboratories aligned with Hepalink’s broader strategy, allowing the Wisconsin operation to broaden its global supply chain. Shawn Lu, Hepalink USA’s chief financial officer, says Wisconsin’s favorable business climate and supporting attributes helped the company build on its success.

“Wisconsin has a stable workforce, well-trained technicians, and skilled workers; a highly developed and respected education system; reasonable labor costs; and low land and utility costs,” Lu adds.

AT A GLANCE

Company: Hepalink

Idea: Expand global markets and supply chain by acquiring Waunakee-based Scientific Protein Laboratories

Reason: Wisconsin’s favorable business climate and a host of other benefits, including a strong education system

Related Posts

Go to Top